000 01363 a2200397 4500
005 20250517232817.0
264 0 _c20181211
008 201812s 0 0 eng d
022 _a1477-7819
024 7 _a10.1186/s12957-018-1472-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMori, Ryutaro
245 0 0 _aThe mode of progressive disease affects the prognosis of patients with metastatic breast cancer.
_h[electronic resource]
260 _bWorld journal of surgical oncology
_cAug 2018
300 _a169 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aDisease Progression
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aPrognosis
650 0 4 _aResponse Evaluation Criteria in Solid Tumors
650 0 4 _aRetrospective Studies
650 0 4 _aSurvival Analysis
700 1 _aFutamura, Manabu
700 1 _aMorimitsu, Kasumi
700 1 _aAsano, Yoshimi
700 1 _aTokumaru, Yoshihisa
700 1 _aKitazawa, Mai
700 1 _aYoshida, Kazuhiro
773 0 _tWorld journal of surgical oncology
_gvol. 16
_gno. 1
_gp. 169
856 4 0 _uhttps://doi.org/10.1186/s12957-018-1472-9
_zAvailable from publisher's website
999 _c28730014
_d28730014